Marine Derived Proteins Market By Source Type (Fish Proteins, Algal Proteins, Shellfish Proteins, Other Marine Protein Sources); By Application (Food and Beverages, Nutraceuticals and Dietary Supplements, Cosmetics and Personal Care, Pharmaceuticals, Animal Feed and Pet Nutrition); By End User (Food Manufacturers, Nutraceutical Companies, Cosmetics Companies, Pharmaceutical and Biotechnology Companies, Animal Nutrition Companies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ocean-Sourced Proteins: Unlocking Nutritional Potential from Marine Resources - (Updated On: 17th-Aug-2026)

The Global Marine Derived Proteins Market was valued at USD 8.72 billion in 2025 and is projected to reach USD 14.94 billion by 2032, expanding at a CAGR of 8.0% during 2026–2032. Fish proteins remain the largest source, accounting for 52.0% of the market, while algal proteins are the fastest-growing source at a 10.6% CAGR. Food and beverages represent the largest application, whereas nutraceuticals and dietary supplements are expanding faster as manufacturers move toward marine collagen peptides, protein hydrolysates and increasingly standardized bioactive peptide fractions.

 

Why is demand for marine-derived proteins increasing?

The main demand driver is the conversion of large aquatic raw-material streams into higher-value functional ingredients. FAO reported that global production reached 235 million tonnes of aquatic animals and algae in 2024, including 195 million tonnes of aquatic animals. Aquaculture production of aquatic animals reached 103 million tonnes, exceeding 100 million tonnes for the first time. This enlarges the processing base from which skins, frames, scales and other fractions can be recovered and upgraded into higher-value protein ingredients.

The market is expanding through two distinct value propositions. Conventional proteins continue to serve food, feed and pet nutrition, while premium growth is increasingly associated with collagen peptides, hydrolysates and standardized functional fractions for supplements, beauty nutrition and specialized foods. Technical research identifies seafood-processing residues as protein-rich feedstocks and describes enzymatic hydrolysis and peptide purification as routes for converting them into more valuable ingredients.

 

Which marine protein source has the largest market share?

Fish proteins are the largest source segment, with a 52.0% share and USD 4.53 billion in 2025 revenue, and are projected to expand at a 7.2% CAGR. Their position reflects established seafood-processing infrastructure and the ability to manufacture collagen, gelatin, protein concentrates and hydrolyzed peptides from existing fish-processing streams.

Fish skins are particularly important for marine collagen. Weishardt's Naticol platform uses fish-skin collagen and enzymatic processing to manufacture formulation-ready marine collagen peptides. This production model demonstrates how seafood side streams can be converted into standardized ingredients for supplements, functional foods and beverages rather than remaining low-value processing residues.

Algal proteins are the fastest-growing source, representing 21.0% or USD 1.83 billion in 2025 and expanding at a 10.6% CAGR. Their higher growth reflects controlled cultivation, access to multiple strains and the possibility of integrating protein production with recovery of pigments, lipids and other compounds. Their strategic importance does not yet imply displacement of fish proteins because cultivation, harvesting, cell disruption and purification remain comparatively demanding processing steps.

Industrial capacity is nevertheless moving forward. In July 2025, the EU-backed SCALE project opened a more than 5,000 m² industrial-scale microalgae biorefinery in France capable of producing more than 100 tonnes per year of natural active ingredients. The consortium reported that 11 ingredients developed through the project had already been commercialized in around 15 countries.

Shellfish proteins accounted for 19.0% or USD 1.66 billion and have a 7.7% CAGR, supported by crustacean-derived protein and peptide ingredients across food, nutrition and feed applications. Other sources represent 8.0% or USD 0.70 billion and grow at 6.5%, keeping them smaller than fish, algae and shellfish through the forecast period.

 

Which applications generate the strongest demand for marine-derived proteins?

Food and beverages are the largest application, accounting for 35.0% or USD 3.05 billion in 2025, with a 7.4% CAGR. Manufacturers increasingly evaluate marine proteins according to solubility, protein concentration, taste, odor, heat stability and compatibility with beverages, powders and fortified foods. Improvements in hydrolysis and purification are widening the number of products in which fish proteins and collagen peptides can be formulated.

Nutraceuticals and dietary supplements hold 27.0% of the market, or USD 2.35 billion, and are projected to expand at a 9.3% CAGR. The corresponding end-user category—nutraceutical and supplement brands—accounts for 26.0% or USD 2.27 billion and has the fastest end-user CAGR at 9.4%. This is commercially important because supplements can support branded, application-specific peptides rather than purely commodity protein pricing.

Retail commercialization confirms that marine collagen has moved into mainstream supplement formats. Vital Proteins currently markets a marine collagen product containing 12 grams of collagen peptides per serving, made from wild-caught cod scales. GELITA also markets fish-sourced products within its VERISOL bioactive collagen peptide platform, providing another example of marine proteins moving toward specialized beauty and wellness positioning.

Cosmetics and personal care represent 12.0% or USD 1.05 billion and are growing at an 8.8% CAGR. Cosmetics companies account for the same 12.0% end-user share and carry an 8.7% CAGR. Marine collagen and algae-derived ingredients increasingly connect ingestible beauty with topical-product development. CHANEL, for example, participated in the SCALE consortium and tested microalgae-based ingredients for potential skincare and makeup applications.

Pharmaceuticals account for 10.0% or USD 0.87 billion and carry an 8.5% CAGR. Pharmaceutical and biotechnology applications remain smaller because they require tighter characterization, purity, safety and reproducibility than conventional food ingredients. Marine collagen and bioactive peptides nevertheless continue to be studied for biomedical and therapeutic applications, creating a longer-term high-value pathway distinct from established food and supplement demand.

Animal feed and pet nutrition represent 16.0% or USD 1.40 billion and grow at a 6.5% CAGR. Demand in this segment depends more heavily on digestibility, palatability, nutrient density, feed performance and viable inclusion cost. The former Aker BioMarine Feed Ingredients business now operates independently as Aker QRILL Company, with QRILL Aqua and QRILL Pet serving aquaculture and animal nutrition markets.

 

How are marine-derived proteins processed and purchased?

Marine proteins are increasingly purchased according to functional specification rather than biological source alone. Relevant qualification criteria include protein concentration, peptide molecular profile, solubility, taste and odor, microbiological quality, contaminant controls, species traceability, allergen status and consistency between production batches.

Enzymatic hydrolysis is central to this value shift because processing conditions can influence the size and characteristics of the resulting peptides. Research on marine protein processing identifies enzymatic hydrolysis and microbial fermentation as important routes for releasing bioactive peptides, while ultrafiltration is widely used to separate hydrolysates into peptide fractions for further purification.

Membrane technology can also address some limitations of conventional batch hydrolysis. Research reviewed in Food Innovation and Advances describes a recirculating three-stage membrane reactor in which enzymes can be reused while peptides are separated according to molecular-weight cut-offs. Such systems illustrate how industrial peptide manufacturing could improve enzyme utilization while producing more controlled fractions.

Microalgae involve a different processing chain consisting of cultivation, biomass harvesting, cell disruption, extraction and purification. This difference helps explain why algal proteins can grow at 10.6% without immediately replacing fish proteins. Fish processors benefit from mature side-stream supply, while algae producers offer more controlled biological production but face additional capital and downstream-processing requirements.

 

What regulations and standards affect marine-derived proteins?

Food-allergen labeling is one of the clearest regulatory factors affecting fish- and crustacean-derived proteins in the United States. FDA identifies fish and Crustacean shellfish among the nine major food allergens, and foods containing protein derived from major allergens are subject to applicable source-labeling requirements.

Species identification matters for marine ingredients. FDA guidance distinguishes Crustacean shellfish such as shrimp, crab and lobster from molluscan shellfish such as oysters, clams, mussels and scallops; the latter are not classified as major food allergens under the same statutory definition. This affects formulation review and labeling obligations when manufacturers switch between different marine protein sources.

Algal ingredients face a different regulatory question: whether a species or derived ingredient is novel for food use. In February 2024, the European Commission reported that more than 20 algae species had been added to the EU Novel Food Status Catalogue, taking the catalogue to more than 60 algae-related entries. Qualifying species with established food-use history can avoid the pre-market novel-food authorization route, while genuinely novel ingredients remain subject to applicable EU requirements.

 

Which region has the strongest marine protein supply position?

Asia has the strongest raw-material position because it dominates global aquatic production and algae cultivation. FAO reported that Asia produced 179 million tonnes of aquatic animals and algae in 2024, representing 76% of global output, and accounted for 97% of almost 40 million tonnes of global algae production. China alone produced 57.6 million tonnes of farmed aquatic animals.

This concentration gives Asian processors access to large fish, shellfish and algal biomass streams and supports integration across aquaculture, seafood processing, extraction and feed manufacturing. It also provides a strong supply base for future algal protein development, although advanced fractionation, branded ingredient development and regulatory market access determine how much downstream value producers capture.

Supply concentration creates exposure as well as scale. FAO GLOBEFISH reported that global seaweed export volume declined 4.4% during January–September 2025, while export value increased 9.4%, indicating higher average export prices. For processors reliant on selected algae species, regional production and trade movements can therefore affect raw-material economics.

Europe is developing a stronger position in specialized and higher-value marine ingredients. The SCALE biorefinery in France illustrates industrial microalgae commercialization, while Hofseth BioCare's planned Berkåk expansion shows continuing investment in fish-derived enzymatic hydrolysis. Europe also benefits from regulatory work expanding the number of algae species recognized for food and supplement use.

North America has an established downstream market for marine collagen and dietary supplements, demonstrated by commercial marine collagen formats from consumer nutrition brands. U.S. allergen-labeling requirements nevertheless create explicit formulation and documentation obligations for fish- and crustacean-derived proteins.

Latin America has feedstock relevance through its substantial fisheries and aquaculture base. FAO reported 17.8 million tonnes of aquatic animals in Latin America and the Caribbean in 2024, with high-value aquaculture led partly by salmon in Chile and shrimp in Ecuador. These industries generate processing side streams that can support collagen and protein valorization when suitable local processing capacity is available.

 

Major Companies in the Marine Derived Proteins Market

Competition includes marine-biotechnology companies, collagen specialists, seafood side-stream processors, krill ingredient companies and algae developers. Increasingly, competitive advantage depends on control of raw materials, peptide specification, processing know-how, traceability, application support and scientific substantiation rather than simply offering marine protein by weight.

Hofseth BioCare ASA — Norway's Marine Upcycling Specialist Advancing Salmon Bioactive Peptides

Hofseth BioCare converts Norwegian salmon-processing side streams into protein, collagen and other marine ingredients. Its strategic agreement with Symrise and planned expansion at Berkåk demonstrate a strategy centered on enzymatic hydrolysis, higher-value human-health ingredients and stronger downstream distribution rather than commodity fish protein alone.

Weishardt Group — Marine Collagen Specialist Building Precision around the Naticol Platform

Weishardt competes through Naticol marine collagen peptides produced from fish skins. Its x3Peptide product takes the strategy further by specifying a minimum 25% tripeptide concentration, demonstrating how branded suppliers are differentiating around peptide composition, formulation performance and traceable sourcing.

Rousselot — Global Collagen Supplier Expanding Fish-Derived Peptan through Certified Circular Sourcing

Rousselot supplies Peptan collagen peptides from bovine, porcine and fish sources. Its fish-derived collagen carries sustainability certifications, while the broader Peptan range has Upcycled Certified status. The company's positioning combines marine sourcing, formulation versatility and branded collagen science for nutrition and wellness applications.

GELITA AG — Bioactive Collagen Developer Extending VERISOL into Fish-Sourced Beauty Nutrition

GELITA offers fish-sourced formulations within its VERISOL Bioactive Collagen Peptides portfolio. The company competes around application-specific peptide fingerprints and beauty-from-within positioning, illustrating the shift from generic collagen toward branded compositions intended for particular consumer-health uses.

Aker BioMarine ASA — Krill-Based Human Health Ingredient Specialist

Aker BioMarine's current strategy is increasingly concentrated on human-health ingredients following the September 2024 divestment of its Feed Ingredients business. Its former aquaculture and animal-nutrition operations are therefore no longer appropriately described as part of the same current competitive structure.

Aker QRILL Company — Independent Krill Ingredient Supplier for Aquaculture and Animal Nutrition

Aker QRILL Company was launched in November 2024 from the former Aker BioMarine feed and fishing business. It currently develops QRILL Aqua and QRILL Pet ingredients and provides krill-based raw materials for aquaculture and animal-nutrition applications.

Symrise AG — Global Ingredient Company Building Marine Exposure through Strategic Partnerships

Symrise is expanding its marine-ingredient exposure through its partnership with Hofseth BioCare. The arrangement links Symrise's customer access and ingredient-distribution capabilities with Hofseth's marine raw-material processing, illustrating how large ingredient groups can participate in marine protein growth without owning the complete upstream seafood value chain.

Other relevant participants include Copalis, Seagarden, Scanbio Marine Group, Biomega Group, Corbion and Algama, depending on the exact source, ingredient definition and end application. Their competitive relevance should be assessed against the final report scope because the broader marine-ingredient industry also includes oils, minerals, whole biomass and other products that fall outside a strict marine-protein definition.

 

How are competition and forecast risks changing?

Competition is shifting from access to marine biomass toward control of the complete ingredient proposition. Customers increasingly evaluate peptide profile, sensory characteristics, traceability, regulatory documentation, scientific support, formulation compatibility and security of supply. This favors suppliers that can convert marine side streams into reproducible, application-specific ingredients rather than competing primarily on bulk protein volume. Commercial developments from Hofseth BioCare, Weishardt and Rousselot demonstrate this movement toward more differentiated marine peptide portfolios.

The revenue opportunity also varies substantially by application. Conventional food and feed provide volume, while nutraceuticals, sports nutrition, beauty-from-within and specialized health products provide more room for branded ingredients and peptide-specific differentiation. This supports the supplied market structure in which nutraceutical and supplement brands are the fastest-growing end-user category at 9.4% CAGR, despite food and beverage manufacturers remaining the largest at 34.0% or USD 2.96 billion in 2025.

The principal forecast constraint is the ability to scale consistent peptide and protein production without losing cost competitiveness. Research continues to identify industrial scale-up, repeatability, sustainable raw-material supply and clinical validation as barriers to broader commercialization of marine bioactive peptides. Enzymatic processes can also be more expensive than some conventional hydrolysis approaches, while more targeted purification adds downstream cost.

Evidence quality is another commercial constraint. The biological mechanisms surrounding marine peptides are expanding faster than the body of controlled human evidence for several applications. Sports nutrition provides a clear example: a 2026 review found relatively limited controlled athletic-performance evidence for several marine bioactives even where mechanistic or animal data are promising. Gut-health evidence for octopus, scallop and sea-conch peptides similarly remains predominantly preclinical.

The market is therefore developing along two speeds. Fish proteins and established marine collagen products remain the revenue anchor, while algal proteins and precisely characterized bioactive peptides are gaining strategic importance. The largest commercial gains are likely to accrue to suppliers that can connect marine raw-material access with reproducible peptide profiles, acceptable sensory performance, credible clinical evidence and cost-effective industrial manufacturing.

 

Marine Derived Proteins Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 8.72 Billion
Revenue Forecast in 2032	USD 14.94 Billion
Overall Growth Rate	CAGR of 8.0% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Source Type, By Application, By End User, By Geography
By Source Type	Fish Proteins, Algal Proteins, Shellfish Proteins, Other Marine Protein Sources
By Application	Food and Beverages, Nutraceuticals and Dietary Supplements, Cosmetics and Personal Care, Pharmaceuticals, Animal Feed and Pet Nutrition
By End User	Food Manufacturers, Nutraceutical Companies, Cosmetics Companies, Pharmaceutical and Biotechnology Companies, Animal Nutrition Companies
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	- Rising demand for sustainable protein sources and marine-resource valorization. - Growing adoption of marine collagen peptides and protein hydrolysates in functional nutrition and beauty products. - Increasing investment in algae cultivation, enzymatic extraction, and marine biotechnology solutions.
Customization Option	Available upon request